Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Proton Therapy vs IMRT/VMAT for Cervical Cancer
NCT05406856Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2022
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Mean Dose to the Pelvic Bones and Mean V15Gy to the Bowel. Started May 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05406856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05406856.